Please login first

The 4th International Online Conference on Biomedicines

Part of the International Electronic Conference on Biomedicines series
10–12 May 2027
Event's Timezone: Central European Summer Time
Abstract Submission Deadline
15 January 2027
Abstract Acceptance Notification
15 March 2027

Registration Deadline
5 May 2027

Immunology, Metabolic Diseases, Neuroscience, Cardiovascular Disease, Cancer Biology, Regenerative Medicine, Translational Medicine, Nanomedicine, Artificial Intelligence in Biomedicine
Bookmark
Bookmark event Remove event from bookmarks
Add this event to bookmarks
Event Registration Contact Us
The ECB 2027 Conference is Now OPEN for Abstract Submission and Registration.

Submit your abstracts HERE.
Instructions for authors are available online.

For any inquiries, please contact us at ecb@mdpi.com.

Welcome from the Chairs

Dear Colleagues,

Building on the success of the 2025 edition, we are pleased to announce the 4th International Online Conference on Biomedicines (ECB 2027). This event will once again bring together leading researchers from around the world to share the latest advances in biomedicine. The conference will take place online from 10 to 12 May 2027, organized by the journal Biomedicines (ISSN: 2227-9059; Impact Factor: 3.9; CiteScore: 6.8), a peer-reviewed open access journal published by MDPI.

The conference aims to provide a global platform for scientists and researchers to exchange ideas, discuss emerging challenges, and present recent research achievements in the field of biomedicine. The program will include, but is not limited to, the following topics:
S1. Immune System, Tumor Immunology and Autoimmune Disease
S2. Diabetes, Obesity and Metabolic Diseases
S3. Neuroscience and Neurodegeneration
S4. Cardiology and Cardiovascular Diseases
S5. Cancer Molecular Biology and Precision Medicine
S6. Bone Biology and Regenerative Medicine
S7. Translational Medicine and Nanomedicine
S8. AI in Biomedicine

We warmly invite researchers to submit their abstracts. All submissions will undergo MDPI’s standard peer-review process. After the conference, authors will be invited to submit a full proceeding paper (4–8 pages in length), which will be published in Medical Sciences Forum (ISSN 2673-9992) free of charge. In addition, participants are encouraged to submit a full manuscript to the conference’s Special Issue in Biomedicines, with a 20% discount on the article processing charge (APC).

To acknowledge the support of the conference's esteemed authors and to recognize their outstanding scientific accomplishments, we are pleased to announce that the conference will provide six awards, including Best Oral Presentation Awards and Best Poster Awards. The winners will each receive a certificate and 200 CHF.

We look forward to your contribution in this exciting event.

Best regards,

Conference Chairs
Prof. Dr. Felipe Fregni
Prof. Dr. Georgia Levidou
Assoc. Prof. Dr. Allan Stensballe
Dr. Timo Gaber

Follow the conference organizer on Social Media

Event Chairs

Physical Medicine and Rehabilitation, Harvard Medical School, USA

Introduction
Bio
Prof. Dr. Fregni is a Professor of epidemiology at Harvard T.H. Chan School of Public Health and PM&R at Harvard Medical School. He leads a large clinical research laboratory (Spaulding Neuromodulation Center) funded by major NIH grants and is currently investigating techniques to guide and measure neuroplasticity in brain injury. He has been at the forefront of advancing neurorehabilitation science to treat conditions such as stroke, Parkinson’s disease, and chronic pain. In recognition of his outstanding contributions, he has been awarded the highest honor bestowed by the United States government to outstanding scientists and engineers in the U.S.: the Presidential Early Career Award for Scientists and Engineers (PECASE).

Department of Pathology, Paracelsus medical University, Nuremberg, Germany

Introduction
Bio
Prof. Dr. Georgia Levidou is a consultant Pathologist at the Department of Pathology, Paracelsus medical university in Nuremberg, Germany. She received her medical degree (MD), PhD and MSc in Biostatistics at the University of Athens, Greece. She has a twenty years’ experience on pathology and research acquired in leading research centers and is an author of more than 87 peer-reviewed articles. Her research interests span both cancer diagnostics, cellular and molecular pathology as well as tumor prognostic and therapeutic biomarkers. Prof. Levidou has a special interest in hematopathology and is currently working especially on the field of thymic epithelial tumors.

Department of Health Science and Technology, Aalborg University, Denmark

Introduction
Bio
Dr. Allan Stensballe is a prominent figure in the fields of proteomics, systems biology, inflammation, biomarker discovery, and omics data analysis. He is current council member of the Human Proteome organization. He is associated with Aalborg University's Department of Health Science. Dr. Stensballe's expertise is deeply rooted in proteomics and the application of proteomics for understanding human disease pathology, especially in the context of precision medicine. He has been pivotal in leading the precision health segment of the Laboratory for Precision health research group at Aalborg University in Denmark. This initiative aims to bridge the gap between academic research and small to medium-sized enterprises (SMEs) through technology-driven innovation, particularly in crucial areas that impact global health and wellness.

Department of Medicine, Division of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Berlin, Germany

Introduction
Bio
Dr. Timo Gaber is specializing in inflammatory and autoimmune diseases, with a focus on immunometabolism, cellular signaling, and the molecular mechanisms underlying chronic inflammation. His work explores how metabolic processes influence immune cell function, contributing to the development of targeted therapeutic strategies in rheumatology and clinical immunology.

Registration


The registration for ECB 2027 will be free of charge! The registration includes attendance to all conference sessions.

If you are registering several people under the same registration, please do not use the same email address for each person, but their individual university email addresses. Thank you for your understanding.

Please note that the submission and registration are two separate parts. Only scholars who registered can receive a link to access the conference live streaming. The deadline for registration is 5 May 2027.

Instructions for Authors

Procedure for Submission

ECB 2027 will accept abstracts only. The accepted abstracts will be available online on Sciforum.net during and after the conference.

Abstract submissions should be completed online by registering with www.sciforum.net and using the "Submit Abstract" function once logged into the system.

Important Deadline
Deadline for abstract submission: 15 January 2027
Abstract acceptance notification: 15 March 2027
You will be notified of the acceptance of an oral/poster presentation in a separate email after the abstract has been accepted.

Abstract Submission Requirements


1. The abstract structure should include the introduction, methods, results, and conclusions sections of about 250–300 words in length.
2. All abstracts should be submitted and presented in clear, publication-ready English with accurate grammar and spelling.
3. The submitting author must ensure that all co-authors are aware of the contents of the abstract.
4. You may submit multiple abstracts. However, only one abstract will be selected for oral presentation.
5. Please select only one presenter for each submission. If you would like to change the presenter after submission, please email us (ecb@mdpi.com) accordingly.
6. The abstracts submitted to this conference must be original and novel, without prior publication in any journals, or it will not be accepted to this conference.
7. For review articles, only systematic reviews and meta-analyses are accepted. MDPI requires authors to include a completed PRISMA checklist and flow diagram (or a similar reporting checklist) as part of the main text or supplementary materials. Relevant registration information (e.g., PRISMA, if available) should be stated in the Methods section for the systematic reviews and meta-analyses. Common types of review articles that are not acceptable:
- Comparative review
- Comprehensive review
- Scoping review
- Literature review/Narrative review
- Perspective/Opinion
- Essay
8. No physical template is necessary.

Important Notes:
1. We only accept live presentations for oral presentation.
2. As for the poster type, please be informed that there is no LIVE presentation required for this type. Your poster will only be displayed exclusively in the Poster Gallery since the event date.

Oral Presentation and Slides Preparation

The slot for the oral presentation is 15 mins including 3 minutes of discussion. We advise that your presentation lasts for a maximum of 12 mins, leaving at least 3 mins for the Q&A session.

Authors are encouraged to prepare a presentation in PowerPoint or similar software. Slides can be prepared in exactly the same way as for any traditional conference where research results are presented. Slides should also be converted to PDF format prior to submission so that they can be converted for online display.

Note: Only live presentations are accepted; recorded presentations are not allowed. Please confirm your participation at least two weeks before the event date.

Poster

All authors are welcome to submit a poster after their abstract has been accepted. The poster should be uploaded to the Sciforum website at least two weeks before the conference dates. We will contact you closer to the event with further details.

Please be informed that there is no LIVE presentation required for this type. Your poster will only be displayed exclusively in the Poster Gallery since the event date. However, poster submissions are still eligible for the Best Poster Award.

Poster Requirements:
1. Should include the title, authors, contact details and main research findings, as well as tables, figures and graphs where necessary.
2. Size in pixel: 1080 width x 1536 height–portrait orientation.
3. Size in cm: 38,1 width x 54,2 height–portrait orientation.
4. Font size: ≥16.
5. Examples of successful submissions can be viewed here at the following links: (1), (2), (3).
6. You can use our free template to create your poster.

The poster template can be downloaded HERE.

Certificates of Participation
The certificate will be available in your logged-in area of Sciforum.net, under "My Certificates" after the conference.

Potential Conflicts of Interest

It is the author's responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.

Copyright

MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the Sciforum.net platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.

Event Awards

To acknowledge the support of the conference's esteemed authors and recognize their outstanding scientific accomplishments, we are pleased to announce that the conference will provide 6 awards including the Best Oral Presentation Award and the Best Poster Award.

The Awards
Best Oral Presentation Award and Best Poster Award

Number of Awards Available: 6

The winners of Best Oral Presentation and Best Poster Award will receive a certificate with 200 CHF each.

Terms and Conditions:

1. Eligibility
- Awards are open to all participants who present their work at the ECB 2027 Conference in the eligible presentation categories (e.g., oral or poster presentations), unless otherwise specified.
- Only presentations that are delivered as scheduled during the conference will be considered.
2. Evaluation Process
- All eligible presentations will be evaluated based on scientific quality, originality, clarity of presentation, and relevance to the conference themes.
- The evaluation will be conducted by the assigned session chair(s) and reviewed and confirmed by the event chair(s).
3. Decision Authority
- The final decision regarding award recipients is subject to the professional judgment and approval of the session chair(s) and event chair(s).
- All decisions are final and not subject to appeal.
4. Announcement of Awards
- Award recipients will be announced after the conclusion of the ECB 2027 Conference.
- The official announcement will be made through the conference website and via direct email notification to the awardees.
5. Amendments
- The ECB 2027 Organizing Committee reserves the right to amend these Terms and Conditions at any time, if necessary, with appropriate notice.

Publication Opportunities

  1. Biomedicines Journal Publication
    Participants in this conference are cordially invited to contribute a full manuscript to the conference's Special Issue(to be updated), published in Biomedicines (ISSN: 2227-9059, Impact Factor 3.9), with a 20% discount on the publication fee. Please note, if you have IOAP/association discounts, conference discounts will be combined with IOAP/association discounts. Conference discounts cannot be combined with reviewer vouchers. All submitted papers will undergo MDPI’s standard peer-review procedure. The abstracts should be cited and noted on the first page of the paper.

  1. Proceeding Paper Publication
    Authors of accepted abstracts are highly encouraged to submit an extended proceeding paper (ideally 4–8 pages in length) for the conference's dedicated proceedings volume in the Medical Sciences Forum Journal (ISSN 2673-9992) for free. Please submit it after the conference.

    Proceeding paper submission deadline: 26 June 2027 (45 days after the conference)

    Please click HERE to submit your proceeding paper to the Medical Sciences Forum Journal, and be sure to disclose the conference information in your cover letter or mention the conference name in your submission.
    ECB2027_proceeding_paper-template.dot

    Publication Notice: Proceeding papers will undergo peer-review procedure. Acceptance at the conference does not ensure final publication.

Sponsors and Partners

Organizers


Media Partners

Conference Secretariat

Suriwipa Chuachaina
Coco Hou
Eastern Zhuang
Liane Zhong

For inquiries regarding submissions and sponsorship opportunities, please feel free to contact us.
Email: ecb@mdpi.com

Top